Skip to content
Recall Observatory FDA recall evidence

Drug product

Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037, NDC 61919-422-30

D-0567-2025

March 07, 2025

Class II

Product summary

Firm
Direct Rx
Event
Event 97251
Status
Ongoing
Classification
Class II
Quantity
16 bottles
Official record key
drug-enforcement:D-0567-2025

Official wording

Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Code information: Lot #: 02AU2406, Exp 01/31/2027

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Nitrosamine Drug Substance Related Impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations